International Workshop on Science-Based Drug Reimbursement Policy in Vienna

Wien (OTS) - This workshop is being held on Thursday and Friday,
15 and 16 of September 2005 in Vienna. It is a discussion platform
for health care decision-makers and reimbursement authorities in
Europe.

The topics being discussed are:

1) Creating an electronic platform for cooperation among agencies
responsible for reimbursement of pharmaceuticals

2) Efficient and affordable supply of orphan drugs for patients
with rare diseases

3) Identifying new drugs with real additional patient benefit and
distinguishing them from "me-too"-products with no added therapeutic
value

4) Implementing strategies which ensure that reimbursers only pay
for drugs if they really benefit patients.

The Department of Pharmaceutical Affairs of the Hauptverband der
Österreichischen Sozialversicherungsträger (Main Association of
Austrian Social Security Institutions) cooperates with health
authorities responsible for pricing and reimbursement of medicines
(Ministries of Health and Social Health Insurance Institutions -
so-called "Third Party Payers"), academic institutions (Medical
University of Vienna, Vienna School of Clinical Research) and the
World Health organisation (WHO/EURO).

The objective of this workshop is to exchange information and to
explore cooperation among European health care decision-makers and
social reimbursement organizations. They will discuss current issues
related to pharmaceutical policy, resource allocation and scientific
assessment of products.

More than 70 persons from 23 countries are attending the meeting.
They are representatives of national institutions which are
responsible for reimbursement of medicines within EU member and EU
candidate states as well as Norway, Switzerland and Iceland.

Rückfragehinweis:
Hauptverband der österr. Sozialversicherungsträger
Dr. Wilhelm Donner
Tel.: 711 32/1124

OTS-ORIGINALTEXT UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS | NHS

print